Now live: Pro — the full 13F research suite for serious investorsSee pricing →
BFAM Partners (Cayman) Ltd

Q2 2024 · 13F-HR

BFAM Partners (Cayman) Ltdholdings as filed

Filed 2024-08-13 · accession 0001639101-24-000004

$37,455
Reported value
1
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
G9845F117LSBWFLAKESHORE BIOPHARMA CO LTD$37,455100.0%550,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.